<scp>PD</scp>‐1 expression on peripheral blood T‐cell subsets correlates with prognosis in non‐small cell lung cancerKayoko Waki, Akira Yamada, Teppei Yamada et al.|Cancer Science|2014Cited by 93
Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung CancerKoichi Takayama, Yoichi Nakanishi, Shunichi Sugawara et al.|Journal of Immunology Research|2016Cited by 25
Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung CancerShinjiro Sakamoto, Tetsuro Sasada, Teppei Yamada et al.|Clinical Lung Cancer|2017Cited by 15
Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimensTeppei Yamada, Kyogo Itoh, Yasuhiro Terazaki et al.|International Journal of Oncology|2014Cited by 14
Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patientsShigetaka Suekane, Masanori Noguchi, Shigeru Yutani et al.|International Journal of Oncology|2020Cited by 6